Exposure-response relationship for bedaquiline, delamanid, and their metabolites

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Investigating the treatment shorting potential of sutezolid-containing regimens in a murine model with confirmed drug exposures

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Operational Challenges with Centralising PK Bioanalysis in a Multicentre Multinational Randomised Controlled Trial

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Optimized loading period strategies for bedaquiline at the restart of drug-resistant tuberculosis treatment

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Pentamidine shows promising activity against M. tuberculosis and M. avium complex but not M. abscessus

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Pharmacokinetics of linezolid in Indian patients with multidrug-resistant tuberculosis

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Pharmacokinetics of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

PLASMA BEDAQUILINE LEVELS IN INDIAN MDR-TB PATIENTS

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Population pharmacokinetics of cycloserine, administered as terizidone, in South African children treated for rifampicin-resistant tuberculosis.

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Population Pharmacokinetic Modeling of Pretomanid Dispersible-Tablet Formulation in Healthy Volunteers

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Pravastatin pharmacokinetics when administered simultaneously with first-line tuberculosis treatment

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Rifampin Urine Colorimetry for Evaluation of Tuberculosis Pharmacokinetics

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Simulation by oral dosing of rifapentine-rifabutin exposures for long-acting formulations in a mouse model of tuberculosis preventive therapy

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Persistence on F/TAF versus F/TDF for HIV Pre-Exposure Prophylaxis: A Real-World Evidence Analysis in the United States

HIV Prevention Summit 2021

Community PrEP Service delivery for Female Sex Workers in Ghana

HIV Prevention Summit 2021

Socio-demographics of individuals initiated on HIV pre-exposure prophylaxis (PrEP) in Nigeria

HIV Prevention Summit 2021

Uptake of HIV post-exposure prophylaxis, completion rates and self-reported reasons for non-completion among health care workers at Mbarara Regional Referral Hospital

HIV Prevention Summit 2021

Characterizing Non-Occupational Post Exposure Prophylaxis for HIV in 5 Urban Health Centers of Kampala, Uganda: January 2016 - June 2019

HIV Prevention Summit 2021

Intimate partner violence and gender-based violence among people living with HIV in southern Nigeria

HIV Prevention Summit 2021

Post-Exposure Prophylaxis, Post-Violence Care and Ongoing HIV Risk: Missed Opportunities for HIV Prevention through Pre-Exposure Prophylaxis and Other Interventions

HIV Prevention Summit 2021

Assessing Knowledge About Pre-exposure Prophylaxis at a Higher Education Institution in The Western Cape, South Africa Using Limited Episodes of The MTV Shuga Series

HIV Prevention Summit 2021

Development and implementation of a pre-exposure prophylaxis (PrEP) curriculum for pediatric residents

HIV Prevention Summit 2021

Increasing visibility, uptake and retention of Pre-Exposure Prophylaxis (PrEP) users among men who have sex with men (MSM) in Nairobi, Kenya through let’s Get Real Events (LGR).

HIV Prevention Summit 2021

Understanding barriers to HIV Pre-Exposure Prophylaxis scale up in Lusaka urban.

HIV Prevention Summit 2021